Dexamethasone for the Prevention of Post-operative Nausea and Vomiting in Patients Undergoing Cesarean Sections
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
Patients who present for scheduled (non-emergent) cesarean section will be given either
intravenous dexamethasone or placebo prior to receiving a duramorph containing spinal
anesthetic. The investigators will then compare the incidence of nausea and vomiting and the
use of rescue anti-nausea medications in both groups. Our hypothesis is that patients
receiving dexamethasone prior to duramorph containing spinal anesthesia for cesarean section
will have a significantly lower incidence and severity of PONV at 0, 1, 3, 6, and 24 hours
following surgery.